Signal Peptide Database - Viruses

 Entry Details
ID   268
Source Database   UniProtKB/Swiss-Prot
UniProtKB/Swiss-Prot Accession Number   P04582    (Created: 1987-08-13 Updated: 2008-11-25)
UniProtKB/Swiss-Prot Entry Name   ENV_HV1B8
Protein Name   Envelope glycoprotein gp160
Gene   env
Organism Scientific   Human immunodeficiency virus type 1 (isolate BH8 group M subtype B)
Organism Common   HIV-1
Lineage   Viruses
  Retro-transcribing viruses
    Retroviridae
      Orthoretrovirinae
        Lentivirus
          Primate lentivirus group
Protein Length [aa]   851
Protein Mass [Da]   96644
Features  
TypeDescriptionStatusStartEnd
signal peptide      by similarity   1   32
chain   Envelope glycoprotein gp160      33   851
chain   Surface protein   by similarity   33   506
chain   Transmembrane protein   by similarity   507   851
disulfide bond      by similarity   54   74
disulfide bond      by similarity   119   205
disulfide bond      by similarity   126   196
disulfide bond      by similarity   131   157
disulfide bond      by similarity   218   247
disulfide bond      by similarity   228   239
disulfide bond      by similarity   296   331
disulfide bond      by similarity   378   440
disulfide bond      by similarity   385   413
transmembrane region      potential   680   700
topological domain   Extracellular   potential   33   679
topological domain   Cytoplasmic   potential   701   851
region of interest   V1      131   156
region of interest   V2      157   196
region of interest   V3      296   330
region of interest   V4      385   413
region of interest   V5      456   466
region of interest   Fusion peptide   potential   507   527
region of interest   Immunosuppression   by similarity   571   587
region of interest   Involved in GalCer binding   by similarity   657   662
glycosylation site   N-linked (GlcNAc...)   potential   88   88
glycosylation site   N-linked (GlcNAc...)   potential   136   136
glycosylation site   N-linked (GlcNAc...)   potential   141   141
glycosylation site   N-linked (GlcNAc...)   potential   156   156
glycosylation site   N-linked (GlcNAc...)   potential   160   160
glycosylation site   N-linked (GlcNAc...)   potential   186   186
glycosylation site   N-linked (GlcNAc...)   potential   197   197
glycosylation site   N-linked (GlcNAc...)   potential   230   230
glycosylation site   N-linked (GlcNAc...)   potential   234   234
glycosylation site   N-linked (GlcNAc...)   potential   241   241
glycosylation site   N-linked (GlcNAc...)   potential   262   262
glycosylation site   N-linked (GlcNAc...)   potential   276   276
glycosylation site   N-linked (GlcNAc...)   potential   295   295
glycosylation site   N-linked (GlcNAc...)   potential   301   301
glycosylation site   N-linked (GlcNAc...)   potential   332   332
glycosylation site   N-linked (GlcNAc...)   potential   339   339
glycosylation site   N-linked (GlcNAc...)   potential   356   356
glycosylation site   N-linked (GlcNAc...)   potential   386   386
glycosylation site   N-linked (GlcNAc...)   potential   392   392
glycosylation site   N-linked (GlcNAc...)   potential   401   401
glycosylation site   N-linked (GlcNAc...)   potential   443   443
glycosylation site   N-linked (GlcNAc...)   potential   458   458
glycosylation site   N-linked (GlcNAc...)   potential   606   606
glycosylation site   N-linked (GlcNAc...)   potential   611   611
glycosylation site   N-linked (GlcNAc...)   potential   620   620
glycosylation site   N-linked (GlcNAc...)   potential   632   632
glycosylation site   N-linked (GlcNAc...)   potential   669   669
strand         578   580
helix         543   575
helix         582   588
site   Cleavage; by host furin   by similarity   506   507
short sequence motif   YXXL motif; contains endocytosis signal   by similarity   707   710
lipid moiety-binding region   S-palmitoyl cysteine; by host   by similarity   759   759
coiled-coil region      potential   537   587
coiled-coil region      potential   628   662
SP Length   32
 ----+----1----+----2----+----3----+----4----+----5
Signal Peptide MRVKEKYQHLWRWGWRWGTMLLGMLMICSATE
Sequence MRVKEKYQHLWRWGWRWGTMLLGMLMICSATEKLWVTVYFGVPVWKEATT
TLFCASDAKAYDTEVHNVWATHACVPTDPNPQEVVLV
NVTENFNMWKNDM
VEQMHEDIISLWDQSLKPCVKLTPLCVSLK
CTDLKNDTNTNSSSGRMIME
KGEIK
NCSFNISTSKRGKVQKEYAFFYKLDIIPIDNDTTSYTLTSCNTSV
ITQACPKVSFEPIPIHYCAPAGFAILKCN
NKTFNGTGPCTNVSTVQCTHG
IRPVVSTQLLL
NGSLAEEEVVIRSVNFTDNAKTIIVQLDTSVEINCTRPN
NNTRKKIRIQRGPGRAFVTIGKIGNMRQAHCNISRAKWNATLKQIDSKLR
EQFGN
NKTIIFKQSSGGDPEIVTHSFNCGGEFFYCNSTQLFNSTWSTKGS
NNTEGSDTITLPCRIKQIINMWQEVGKAMYAPPISGQIRCSSNITGLLLT
RDGGN
SNNESEIFRPGGGDMRDNWRSELYKYKVVKIEPLGVAPTKAKRRV
VQREK
RAVGIGALFLGFLGAAGSTMGAASMTLTVQARQLLSGIVQQQNNL
LRAIEGQQHLLQLTVWGIKQLQARILAVERYLKDQQL
LGIWGCSGKLICT
TAVPW
NASWSNKSLEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEK
NEQELLELDKWA
SLWNWFNITNWLWYIKLFIMIVGGLVGLRIVFAVLSIV
NRVRQGYSPLSFQTHLPNPRGPDRPEGIEEEGGERDRDRSIRLVNGSLAL
IWDDLRSL
CLFSYHRLRDLLLIVTRIVELLGRRGWEALKYWWNLLQYWSQ
ELKNSAVNLLNATAIAVAEGTDRVIELVQAAYRAIRHIPRRIRQGLERIL
L
Original MRVKEKYQHLWRWGWRWGTMLLGMLMICSATEKLWVTVYFGVPVWKEATT
TLFCASDAKAYDTEVHNVWATHACVPTDPNPQEVVLVNVTENFNMWKNDM
VEQMHEDIISLWDQSLKPCVKLTPLCVSLKCTDLKNDTNTNSSSGRMIME
KGEIKNCSFNISTSKRGKVQKEYAFFYKLDIIPIDNDTTSYTLTSCNTSV
ITQACPKVSFEPIPIHYCAPAGFAILKCNNKTFNGTGPCTNVSTVQCTHG
IRPVVSTQLLLNGSLAEEEVVIRSVNFTDNAKTIIVQLDTSVEINCTRPN
NNTRKKIRIQRGPGRAFVTIGKIGNMRQAHCNISRAKWNATLKQIDSKLR
EQFGNNKTIIFKQSSGGDPEIVTHSFNCGGEFFYCNSTQLFNSTWSTKGS
NNTEGSDTITLPCRIKQIINMWQEVGKAMYAPPISGQIRCSSNITGLLLT
RDGGNSNNESEIFRPGGGDMRDNWRSELYKYKVVKIEPLGVAPTKAKRRV
VQREKRAVGIGALFLGFLGAAGSTMGAASMTLTVQARQLLSGIVQQQNNL
LRAIEGQQHLLQLTVWGIKQLQARILAVERYLKDQQLLGIWGCSGKLICT
TAVPWNASWSNKSLEQIWNNMTWMEWDREINNYTSLIHSLIEESQNQQEK
NEQELLELDKWASLWNWFNITNWLWYIKLFIMIVGGLVGLRIVFAVLSIV
NRVRQGYSPLSFQTHLPNPRGPDRPEGIEEEGGERDRDRSIRLVNGSLAL
IWDDLRSLCLFSYHRLRDLLLIVTRIVELLGRRGWEALKYWWNLLQYWSQ
ELKNSAVNLLNATAIAVAEGTDRVIELVQAAYRAIRHIPRRIRQGLERIL
L
 ----+----1----+----2----+----3----+----4----+----5
Hydropathies  
 

© 2007-2017 Dr. Katja Kapp, Kassel & thpr.net e. K., Dresden, Germany, last update 2010-06-11